Clarke, L., Rehman, I., Leiblich, A., Bury, J., Ackroyd, R., Stoddard, C., Wyman, A., Harrison, R., Hamdy, F., & Cross, S. (2016). Expression of S100A2, S100A4, S100A6 and S100A7 in oesophageal cancers follows the pattern of expression in the tissues from which they are derived and does not show any significant association with any other clinicopathological parameters. 207, 49–49.

Clarke, L., et al. Expression of S100A2, S100A4, S100A6 and S100A7 in Oesophageal Cancers Follows the Pattern of Expression in the Tissues from Which They Are Derived and Does Not Show Any Significant Association with Any Other Clinicopathological Parameters. 2016, pp. 49–49.

Clarke, L, I Rehman, A Leiblich, J Bury, R Ackroyd, C Stoddard, A Wyman, R Harrison, F Hamdy, and S Cross. 2016. “Expression of S100A2, S100A4, S100A6 and S100A7 in Oesophageal Cancers Follows the Pattern of Expression in the Tissues from Which They Are Derived and Does Not Show Any Significant Association with Any Other Clinicopathological Parameters.” In , 207:49–49.